Friday, September 3, 2010
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Peter Duncan
Director of Business Development
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Sales & Marketing
1 of 3
Previous |
Next
Sales & Marketing
Outsourcing to a High Performance Computing Service Provider Is a Good Idea
Strong research and development programs are vital to the continued success of pharmaceutical and biotechnology companies in today's fiercely competitive markets. By Tsunamic Technologies
No Comments
What is the Real Impact of DTC Advertising on the Physician-Patient Dialogue?
Joe Gattuso, President, and Brad Davidson, PhD, Vice President, MBS/Vox, part of CommonHealth
No Comments
The Value of Assessments in Selection and Development
Increasingly, formal assessments are recognized as adding significant value to selection and development systems. This article describes why this is so, and suggests ways organizations can further increase their value.
No Comments
Applying unconventional thinking to the changing pharma marketplace
How often have you seen marketers repurpose materials for a new format and position it as “breakthrough”?
No Comments
1 of 3
Previous |
Next
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.